II
Iantrek, Inc.
SEC filingBiotechnology · White Plains, NY
Amount raised$34.7Msold at filing
Total offering$42M$7.2M still open
Investors in the raise21count reported to the SEC
FiledAug 21, 2025first sale Aug 19, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Tsontcho IanchulevExecutive Officer, Director
Todd K. SoneDirector
James MazzoDirector
Adam K. SzaronosExecutive Officer, Director
Casey K. TanseyDirector
Robert K. WeinrebDirector
Marc-Andre MarcotteDirector
Jeffry K. WeinhuffDirector
Michael HaydinExecutive Officer
Farrell TysonDirector
Executive officers, directors and promoters as listed on the Form D.